Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Comparison of the clinical characteristics and outcomes of hospitalized adult COVID-19 and influenza patients – a prospective observational study

View ORCID ProfileRaija Auvinen, View ORCID ProfileHanna Nohynek, View ORCID ProfileRitva Syrjänen, View ORCID ProfileJukka Ollgren, Tuija Kerttula, View ORCID ProfileJarkko Mäntylä, View ORCID ProfileNiina Ikonen, Raisa Loginov, Anu Haveri, View ORCID ProfileSatu Kurkela, Kirsi Skogberg
doi: https://doi.org/10.1101/2020.06.29.20140632
Raija Auvinen
1Internal Medicine and Rehabilitation, University of Helsinki and Helsinki University Hospital
2Infectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Raija Auvinen
  • For correspondence: raija.auvinen@helsinki.fi
Hanna Nohynek
2Infectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hanna Nohynek
Ritva Syrjänen
3Public Health Projection and Evaluation Unit, Department of Public Health Solutions, Finnish Institute for Health and Welfare, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ritva Syrjänen
Jukka Ollgren
2Infectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jukka Ollgren
Tuija Kerttula
4HUS Medical Imaging Center, Radiology, Helsinki University Hospital and University of Helsinki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jarkko Mäntylä
5Heart and Lung Center, University of Helsinki and Helsinki University Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jarkko Mäntylä
Niina Ikonen
6Expert Microbiology Unit, Department of Health Security, Finnish Institute for Health and Welfare
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Niina Ikonen
Raisa Loginov
7HUS Diagnostic Center, HUSLAB, Clinical Microbiology, University of Helsinki and Helsinki University Hospital, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anu Haveri
6Expert Microbiology Unit, Department of Health Security, Finnish Institute for Health and Welfare
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Satu Kurkela
7HUS Diagnostic Center, HUSLAB, Clinical Microbiology, University of Helsinki and Helsinki University Hospital, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Satu Kurkela
Kirsi Skogberg
8Inflammation Center, University of Helsinki and Helsinki University Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Objective We compared the clinical characteristics, findings and outcomes of hospitalized patients with coronavirus disease 2019 (COVID-19) or influenza to detect relevant differences.

Methods From December 2019 to April 2020, we recruited all eligible hospitalized adults with respiratory infection to a prospective observational study at the HUS Jorvi Hospital, Finland. Influenza and SARS-CoV-2 infections were confirmed by RT-PCR. Follow-up lasted for at least 30 days from admission.

Results We included 61 patients, of whom 28 were COVID-19 and 33 influenza patients with median ages of 53 and 56 years. Majority of both COVID-19 and influenza patients were men (61% vs 67%) and had at least one comorbidity (68% vs 85%). Pulmonary diseases and current smoking were less common among COVID-19 than influenza patients (5 [18%] vs 15 [45%], P=0.03 and 1 [4%] vs 10 [30%], P=0.008). In chest x-ray at admission, ground-glass opacities and consolidations were more frequent among COVID-19 than influenza patients (19 [68%] and 7 [21%], P < 0.001). Severe disease and intensive care unit (ICU) admission occurred more often among COVID-19 than influenza patients (26 [93%] vs 19 [58%], P=0.003 and 8 [29%] vs 2 [6%], P=0.034). COVID-19 patients were hospitalized longer than influenza patients (6 days [IQR 4-21] vs 3 [2-4], P<0.001).

Conclusion Bilateral ground-glass opacities and consolidations in chest X-ray may help to differentiate COVID-19 from influenza. Hospitalized COVID-19 patients had more severe disease, required longer hospitalization and were admitted to ICU more often than influenza patients, which has important implications for public health policies.

Competing Interest Statement

Raija Auvinen, Kirsi Skogberg, Hanna Nohynek, Ritva Syrjänen and Niina Ikonen report an institutional grant to HUS and THL from the DRIVE project funded by IMI under grant agreement No 777363 during the conduct of the study. Currently, Raija Auvinen is working at THL as a part-time safety physician of a clinical trial on influenza vaccine effectiveness (FinFluHD study), for which THL has received research support from Sanofi Pasteur Inc. FinFluHD study is not related to the current study. Hanna Nohynek is an investigator at THL and coordinates the THL DRIVE project which has received funding from Innovative Medicines Initiative. Ritva Syrjänen is a co-investigator in pneumococcal studies for which THL has received research support from GlaxoSmithKline Biologicals. Currently Ritva Syrjänen is a co-investigator in the FinFluHD study for which THL has received research support from Sanofi Pasteur Inc. Neither of these studies is related to the current study. Other authors declare no competing interests.

Funding Statement

This study was funded by the DRIVE Project, which receives funding from the Innovative Medicines Initiative (IMI) 2 Joint Undertaking under grant agreement No 777363. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation and EFPIA.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Approval was granted by the Local Ethics Committee of the Helsinki University Hospital (Date 3 October 2019, case number: HUS/2517/2018)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data are available from the corresponding author upon reasonable request respecting GDPR and with permission from HUS and THL.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted June 29, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Comparison of the clinical characteristics and outcomes of hospitalized adult COVID-19 and influenza patients – a prospective observational study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Comparison of the clinical characteristics and outcomes of hospitalized adult COVID-19 and influenza patients – a prospective observational study
Raija Auvinen, Hanna Nohynek, Ritva Syrjänen, Jukka Ollgren, Tuija Kerttula, Jarkko Mäntylä, Niina Ikonen, Raisa Loginov, Anu Haveri, Satu Kurkela, Kirsi Skogberg
medRxiv 2020.06.29.20140632; doi: https://doi.org/10.1101/2020.06.29.20140632
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Comparison of the clinical characteristics and outcomes of hospitalized adult COVID-19 and influenza patients – a prospective observational study
Raija Auvinen, Hanna Nohynek, Ritva Syrjänen, Jukka Ollgren, Tuija Kerttula, Jarkko Mäntylä, Niina Ikonen, Raisa Loginov, Anu Haveri, Satu Kurkela, Kirsi Skogberg
medRxiv 2020.06.29.20140632; doi: https://doi.org/10.1101/2020.06.29.20140632

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (51)
  • Cardiovascular Medicine (453)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (158)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5275)
  • Forensic Medicine (3)
  • Gastroenterology (197)
  • Genetic and Genomic Medicine (759)
  • Geriatric Medicine (80)
  • Health Economics (213)
  • Health Informatics (700)
  • Health Policy (361)
  • Health Systems and Quality Improvement (224)
  • Hematology (99)
  • HIV/AIDS (164)
  • Infectious Diseases (except HIV/AIDS) (5904)
  • Intensive Care and Critical Care Medicine (363)
  • Medical Education (105)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (769)
  • Nursing (43)
  • Nutrition (132)
  • Obstetrics and Gynecology (144)
  • Occupational and Environmental Health (234)
  • Oncology (481)
  • Ophthalmology (152)
  • Orthopedics (39)
  • Otolaryngology (95)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (99)
  • Psychiatry and Clinical Psychology (865)
  • Public and Global Health (2028)
  • Radiology and Imaging (350)
  • Rehabilitation Medicine and Physical Therapy (158)
  • Respiratory Medicine (287)
  • Rheumatology (94)
  • Sexual and Reproductive Health (74)
  • Sports Medicine (77)
  • Surgery (110)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)